U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 165

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr9:37430511-37430512
GRCh38:
Chr9:37430514-37430515
GRHPRT202fsPrimary hyperoxaluria, type IILikely pathogenic
(Feb 28, 2023)
criteria provided, single submitter
2.
GRCh37:
Chr9:37424928
GRCh38:
Chr9:37424931
GRHPRC57YPrimary hyperoxaluria, type IILikely pathogenic
(May 21, 2020)
criteria provided, single submitter
3.
GRCh37:
Chr9:37429766
GRCh38:
Chr9:37429769
GRHPRQ178fsPrimary hyperoxaluria, type IILikely pathogenic
(Dec 30, 2021)
criteria provided, single submitter
4.
GRCh37:
Chr9:37429731
GRCh38:
Chr9:37429734
GRHPRQ166*Primary hyperoxaluria, type IILikely pathogenic
(Dec 16, 2021)
criteria provided, single submitter
5.
GRCh37:
Chr9:37426564-37426565
GRCh38:
Chr9:37426567-37426568
GRHPRL107fsPrimary hyperoxaluria, type IILikely pathogenic
(May 18, 2022)
criteria provided, single submitter
6.
GRCh37:
Chr9:37426585-37426598
GRCh38:
Chr9:37426588-37426601
GRHPRE113fsPrimary hyperoxaluria, type IILikely pathogenic
(Mar 18, 2022)
criteria provided, single submitter
7.
GRCh37:
Chr9:37429734-37429735
GRCh38:
Chr9:37429737-37429738
GRHPRA167fsPrimary hyperoxaluria, type IILikely pathogenic
(Mar 17, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr9:37429820
GRCh38:
Chr9:37429823
GRHPRQ196fsPrimary hyperoxaluria, type IILikely pathogenic
(Mar 14, 2022)
criteria provided, single submitter
9.
GRCh37:
Chr9:37426942
GRCh38:
Chr9:37426945
GRHPRnot provided, Primary hyperoxaluria, type IIBenign
(Jul 10, 2021)
criteria provided, multiple submitters, no conflicts
10.
GRCh37:
Chr9:37426804
GRCh38:
Chr9:37426807
GRHPRnot provided, Primary hyperoxaluria, type IIBenign
(Jul 10, 2021)
criteria provided, multiple submitters, no conflicts
11.
GRCh37:
Chr9:37422656
GRCh38:
Chr9:37422659
GRHPRnot provided, Primary hyperoxaluria, type IIBenign
(Jul 10, 2021)
criteria provided, multiple submitters, no conflicts
12.
GRCh37:
Chr9:37432136
GRCh38:
Chr9:37432139
GRHPRnot provided, Primary hyperoxaluria, type IILikely pathogenic
(Sep 6, 2022)
criteria provided, multiple submitters, no conflicts
13.
GRCh37:
Chr9:37430545
GRCh38:
Chr9:37430548
GRHPRnot providedBenign
(Oct 23, 2022)
criteria provided, single submitter
14.
GRCh37:
Chr9:37426634
GRCh38:
Chr9:37426637
GRHPRnot providedBenign
(Sep 19, 2022)
criteria provided, single submitter
15.
GRCh37:
Chr9:37425938
GRCh38:
Chr9:37425941
GRHPRPrimary hyperoxaluria, type II, not provided, Nephrolithiasis/nephrocalcinosis
Benign/Likely benign
(Oct 12, 2022)
criteria provided, multiple submitters, no conflicts
16.
GRCh37:
Chr9:37424938
GRCh38:
Chr9:37424941
GRHPRNephrolithiasis/nephrocalcinosis, not provided, Primary hyperoxaluria, type II
Likely benign
(Oct 5, 2022)
criteria provided, multiple submitters, no conflicts
17.
GRCh37:
Chr9:37426628
GRCh38:
Chr9:37426631
GRHPRnot providedLikely benign
(Sep 23, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr9:37426637
GRCh38:
Chr9:37426640
GRHPRPrimary hyperoxaluria, type II, not providedLikely benign
(Aug 19, 2022)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr9:37432041
GRCh38:
Chr9:37432044
GRHPRnot providedLikely benign
(Jun 14, 2019)
criteria provided, single submitter
20.
GRCh37:
Chr9:37426592
GRCh38:
Chr9:37426595
GRHPRnot provided, Primary hyperoxaluria, type IILikely benign
(Oct 10, 2022)
criteria provided, multiple submitters, no conflicts
21.
GRCh37:
Chr9:37432116
GRCh38:
Chr9:37432119
GRHPRnot providedLikely benign
(Sep 2, 2022)
criteria provided, single submitter
22.
GRCh37:
Chr9:37432114
GRCh38:
Chr9:37432117
GRHPRL282Fnot providedLikely benign
(Oct 3, 2022)
criteria provided, single submitter
23.
GRCh37:
Chr9:37436666
GRCh38:
Chr9:37436669
GRHPRP292SPrimary hyperoxaluria, type IIUncertain significance
(Aug 14, 2020)
no assertion criteria provided
24.
GRCh37:
Chr9:37429813
GRCh38:
Chr9:37429816
GRHPRA193Vnot provided, Inborn genetic diseasesConflicting interpretations of pathogenicity
(Jun 24, 2022)
criteria provided, conflicting interpretations
25.
GRCh37:
Chr9:37425956
GRCh38:
Chr9:37425959
GRHPRnot providedLikely benign
(Aug 7, 2022)
criteria provided, single submitter
26.
GRCh37:
Chr9:37424866
GRCh38:
Chr9:37424869
GRHPRnot provided, Nephrolithiasis/nephrocalcinosis, Primary hyperoxaluria, type II
Likely benign
(Sep 23, 2022)
criteria provided, multiple submitters, no conflicts
27.
GRCh37:
Chr9:37422781
GRCh38:
Chr9:37422784
GRHPRT12Anot provided, Primary hyperoxaluria, type IIConflicting interpretations of pathogenicity
(Oct 9, 2020)
no assertion criteria provided
28.
GRCh37:
Chr9:37422761
GRCh38:
Chr9:37422764
GRHPRR5QPrimary hyperoxaluria, type IIUncertain significance
(Sep 4, 2020)
no assertion criteria provided
29.
GRCh37:
Chr9:37428533
GRCh38:
Chr9:37428536
GRHPRQ153*Primary hyperoxaluria, type IILikely pathogenic
(Sep 26, 2019)
criteria provided, single submitter
30.
GRCh37:
Chr9:37426553
GRCh38:
Chr9:37426556
GRHPRY102*Primary hyperoxaluria, type IILikely pathogenic
(Sep 13, 2019)
criteria provided, single submitter
31.
GRCh37:
Chr9:37424894
GRCh38:
Chr9:37424897
GRHPRE46*Primary hyperoxaluria, type IILikely pathogenic
(Dec 22, 2019)
criteria provided, single submitter
32.
GRCh37:
Chr9:37429746
GRCh38:
Chr9:37429749
GRHPRR171Cnot provided, Primary hyperoxaluria, type IIUncertain significance
(May 3, 2022)
criteria provided, multiple submitters, no conflicts
33.
GRCh37:
Chr9:37432012
GRCh38:
Chr9:37432015
GRHPRV248Inot provided, Primary hyperoxaluria, type IIUncertain significance
(Dec 8, 2021)
criteria provided, multiple submitters, no conflicts
34.
GRCh37:
Chr9:37426638
GRCh38:
Chr9:37426641
GRHPRE131Knot providedConflicting interpretations of pathogenicity
(Oct 29, 2022)
criteria provided, conflicting interpretations
35.
GRCh37:
Chr9:37425906-37425912
GRCh38:
Chr9:37425909-37425915
GRHPRnot providedUncertain significance
(Oct 24, 2022)
criteria provided, multiple submitters, no conflicts
36.
GRCh37:
Chr9:37429778
GRCh38:
Chr9:37429781
GRHPRnot provided, Primary hyperoxaluria, type IIConflicting interpretations of pathogenicity
(Sep 27, 2020)
criteria provided, conflicting interpretations
37.
GRCh37:
Chr9:37428563
GRCh38:
Chr9:37428566
GRHPRR163CPrimary hyperoxaluria, type IIUncertain significance
(Jul 24, 2021)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr9:37426621
GRCh38:
Chr9:37426624
GRHPRR125Qnot provided, Primary hyperoxaluria, type IIUncertain significance
(Jun 16, 2022)
criteria provided, multiple submitters, no conflicts
39.
GRCh37:
Chr9:37436911
GRCh38:
Chr9:37436914
GRHPRPrimary hyperoxaluria, type IIUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
40.
GRCh37:
Chr9:37426543
GRCh38:
Chr9:37426546
GRHPRR99QInborn genetic diseases, Primary hyperoxaluria, type II, not provided
Uncertain significance
(Dec 14, 2022)
criteria provided, multiple submitters, no conflicts
41.
GRCh37:
Chr9:37425969
GRCh38:
Chr9:37425972
GRHPRA89PPrimary hyperoxaluria, type IIUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
42.
GRCh37:
Chr9:37424914
GRCh38:
Chr9:37424917
GRHPRPrimary hyperoxaluria, type IIUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
43.
GRCh37:
Chr9:37432029
GRCh38:
Chr9:37432032
GRHPRD253EPrimary hyperoxaluria, type IIUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
44.
GRCh37:
Chr9:37430610
GRCh38:
Chr9:37430613
GRHPRM234TPrimary hyperoxaluria, type II, not providedUncertain significance
(Feb 15, 2022)
criteria provided, multiple submitters, no conflicts
45.
GRCh37:
Chr9:37430599
GRCh38:
Chr9:37430602
GRHPRF230LPrimary hyperoxaluria, type II, Nephrolithiasis/nephrocalcinosis, not provided
Conflicting interpretations of pathogenicity
(Oct 18, 2022)
criteria provided, conflicting interpretations
46.
GRCh37:
Chr9:37424907
GRCh38:
Chr9:37424910
GRHPRA50VPrimary hyperoxaluria, type II, Nephrolithiasis/nephrocalcinosis, not provided
Uncertain significance
(Sep 7, 2022)
criteria provided, multiple submitters, no conflicts
47.
GRCh37:
Chr9:37424844
GRCh38:
Chr9:37424847
GRHPRC29YPrimary hyperoxaluria, type IIUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
48.
GRCh37:
Chr9:37429789
GRCh38:
Chr9:37429792
GRHPRR185HPrimary hyperoxaluria, type IIUncertain significance
(Apr 27, 2017)
criteria provided, single submitter
49.
GRCh37:
Chr9:37429786
GRCh38:
Chr9:37429789
GRHPRG184EPrimary hyperoxaluria, type IIUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
50.
GRCh37:
Chr9:37436664
GRCh38:
Chr9:37436667
GRHPRL291PPrimary hyperoxaluria, type IIUncertain significance
(Jul 4, 2019)
no assertion criteria provided
51.
GRCh37:
Chr9:37426631
GRCh38:
Chr9:37426634
GRHPRnot providedLikely benign
(Oct 27, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr9:37424838
GRCh38:
Chr9:37424841
GRHPRnot providedLikely benign
(Oct 6, 2022)
criteria provided, single submitter
53.
GRCh37:
Chr9:37426589
GRCh38:
Chr9:37426592
GRHPRNephrolithiasis/nephrocalcinosis, not provided, Primary hyperoxaluria, type II
Likely benign
(Jul 19, 2022)
criteria provided, multiple submitters, no conflicts
54.
GRCh37:
Chr9:37429744
GRCh38:
Chr9:37429747
GRHPRR170Qnot provided, Primary hyperoxaluria, type IIBenign/Likely benign
(Nov 3, 2022)
criteria provided, multiple submitters, no conflicts
55.
GRCh37:
Chr9:37432026
GRCh38:
Chr9:37432029
GRHPRnot providedLikely benign
(Oct 21, 2022)
criteria provided, single submitter
56.
GRCh37:
Chr9:37425959
GRCh38:
Chr9:37425962
GRHPRnot provided, Primary hyperoxaluria, type IIConflicting interpretations of pathogenicity
(Oct 25, 2022)
criteria provided, conflicting interpretations
57.
GRCh37:
Chr9:37430575
GRCh38:
Chr9:37430578
GRHPRnot provided, Primary hyperoxaluria, type IIConflicting interpretations of pathogenicity
(Oct 27, 2022)
criteria provided, conflicting interpretations
58.
GRCh37:
Chr9:37432032
GRCh38:
Chr9:37432035
GRHPRnot providedLikely benign
(Oct 14, 2022)
criteria provided, single submitter
59.
GRCh37:
Chr9:37430575
GRCh38:
Chr9:37430578
GRHPRnot provided, Nephrolithiasis/nephrocalcinosis, Primary hyperoxaluria, type II
Conflicting interpretations of pathogenicity
(Oct 27, 2022)
criteria provided, conflicting interpretations
60.
GRCh37:
Chr9:37426604
GRCh38:
Chr9:37426607
GRHPRnot provided, Primary hyperoxaluria, type IIBenign/Likely benign
(Oct 27, 2022)
criteria provided, multiple submitters, no conflicts
61.
GRCh37:
Chr9:37430644
GRCh38:
Chr9:37430647
GRHPRPrimary hyperoxaluria, type II, not providedLikely pathogenic
(Jun 27, 2022)
criteria provided, multiple submitters, no conflicts
62.
GRCh37:
Chr9:37429826-37429827
GRCh38:
Chr9:37429829-37429830
GRHPRE198fsnot provided, Primary hyperoxaluria, type IIPathogenic
(Aug 2, 2021)
criteria provided, multiple submitters, no conflicts
63.
GRCh37:
Chr9:37424897
GRCh38:
Chr9:37424900
GRHPRR47*Primary hyperoxaluria, type II, not providedConflicting interpretations of pathogenicity
(Sep 23, 2022)
criteria provided, conflicting interpretations
64.
GRCh37:
Chr9:37430524-37430578
GRCh38:
Chr9:37430527-37430581
GRHPRA206fsnot providedPathogenic
(Feb 19, 2019)
criteria provided, single submitter
65.
GRCh37:
Chr9:37432136-37432137
GRCh38:
Chr9:37432139-37432140
GRHPRPrimary hyperoxaluria, type IIUncertain significance
(Jun 3, 2018)
criteria provided, single submitter
66.
GRCh37:
Chr9:37429833
GRCh38:
Chr9:37429836
GRHPRPrimary hyperoxaluria, type IILikely pathogenic
(Apr 11, 2018)
criteria provided, single submitter
67.
GRCh37:
Chr9:37436657-37436658
GRCh38:
Chr9:37436660-37436661
GRHPRL291fsPrimary hyperoxaluria, type IIUncertain significance
(Mar 30, 2018)
criteria provided, single submitter
68.
GRCh37:
Chr9:37436750
GRCh38:
Chr9:37436753
GRHPRE320*Primary hyperoxaluria, type II, not providedConflicting interpretations of pathogenicity
(Nov 1, 2022)
criteria provided, conflicting interpretations
69.
GRCh37:
Chr9:37432003
GRCh38:
Chr9:37432006
GRHPRnot provided, Primary hyperoxaluria, type IILikely pathogenic
(Dec 23, 2021)
criteria provided, multiple submitters, no conflicts
70.
GRCh37:
Chr9:37422748
GRCh38:
Chr9:37422751
GRHPRM1LPrimary hyperoxaluria, type IILikely pathogenic
(Mar 6, 2018)
criteria provided, single submitter
71.
GRCh37:
Chr9:37432133
GRCh38:
Chr9:37432136
GRHPRC288fsPrimary hyperoxaluria, type IILikely pathogenic
(Mar 1, 2018)
criteria provided, single submitter
72.
GRCh37:
Chr9:37426646-37426648
GRCh38:
Chr9:37426649-37426651
GRHPRPrimary hyperoxaluria, type IIUncertain significance
(Feb 2, 2018)
criteria provided, single submitter
73.
GRCh37:
Chr9:37422881
GRCh38:
Chr9:37422884
GRHPRPrimary hyperoxaluria, type IILikely benign
(Dec 21, 2017)
criteria provided, single submitter
74.
GRCh37:
Chr9:37425989-37425991
GRCh38:
Chr9:37425992-37425994
GRHPRnot specified, Primary hyperoxaluria, type IIUncertain significance
(Sep 26, 2022)
criteria provided, multiple submitters, no conflicts
75.
GRCh37:
Chr9:37422881-37422882
GRCh38:
Chr9:37422884-37422885
GRHPRPrimary hyperoxaluria, type IILikely benign
(Dec 9, 2017)
criteria provided, single submitter
76.
GRCh37:
Chr9:37430507
GRCh38:
Chr9:37430510
GRHPRPrimary hyperoxaluria, type IILikely pathogenic
(Nov 27, 2017)
criteria provided, single submitter
77.
GRCh37:
Chr9:37428480
GRCh38:
Chr9:37428483
GRHPRPrimary hyperoxaluria, type IILikely pathogenic
(Oct 6, 2017)
criteria provided, single submitter
78.
GRCh37:
Chr9:37422748
GRCh38:
Chr9:37422751
GRHPRM1VPrimary hyperoxaluria, type IIPathogenic/Likely pathogenic
(Jul 22, 2021)
criteria provided, multiple submitters, no conflicts
79.
GRCh37:
Chr9:37436725-37436726
GRCh38:
Chr9:37436728-37436729
GRHPRN312fsPrimary hyperoxaluria, type IIUncertain significance
(Sep 8, 2017)
criteria provided, single submitter
80.
GRCh37:
Chr9:37432118-37432119
GRCh38:
Chr9:37432121-37432122
GRHPRT284fsPrimary hyperoxaluria, type IILikely pathogenic
(Sep 5, 2017)
criteria provided, single submitter
81.
GRCh37:
Chr9:37428529-37428537
GRCh38:
Chr9:37428532-37428540
GRHPRPrimary hyperoxaluria, type IIUncertain significance
(Aug 25, 2017)
criteria provided, single submitter
82.
GRCh37:
Chr9:37436656
GRCh38:
Chr9:37436659
GRHPRPrimary hyperoxaluria, type IIUncertain significance
(Jul 31, 2017)
criteria provided, single submitter
83.
GRCh37:
Chr9:37424973
GRCh38:
Chr9:37424976
GRHPRPrimary hyperoxaluria, type IILikely pathogenic
(May 31, 2017)
criteria provided, single submitter
84.
GRCh37:
Chr9:37436743-37436744
GRCh38:
Chr9:37436746-37436747
GRHPRE320fsnot provided, Primary hyperoxaluria, type IIConflicting interpretations of pathogenicity
(Mar 1, 2021)
criteria provided, conflicting interpretations
85.
GRCh37:
Chr9:37422749
GRCh38:
Chr9:37422752
GRHPRM1RPrimary hyperoxaluria, type IILikely pathogenic
(Apr 6, 2017)
criteria provided, single submitter
86.
GRCh37:
Chr9:37436778
GRCh38:
Chr9:37436781
GRHPRPrimary hyperoxaluria, type IIUncertain significance
(Apr 6, 2017)
criteria provided, single submitter
87.
GRCh37:
Chr9:37424973
GRCh38:
Chr9:37424976
GRHPRnot provided, Primary hyperoxaluria, type IILikely pathogenic
(Jun 17, 2022)
criteria provided, multiple submitters, no conflicts
88.
GRCh37:
Chr9:37432051-37432052
GRCh38:
Chr9:37432054-37432055
GRHPRG261fsPrimary hyperoxaluria, type II, not providedPathogenic/Likely pathogenic
(Nov 1, 2018)
criteria provided, multiple submitters, no conflicts
89.
GRCh37:
Chr9:37425917-37425918
GRCh38:
Chr9:37425920-37425921
GRHPRPrimary hyperoxaluria, type IILikely pathogenic
(Mar 24, 2017)
criteria provided, single submitter
90.
GRCh37:
Chr9:37432052-37432053
GRCh38:
Chr9:37432055-37432056
GRHPRK262*Primary hyperoxaluria, type IILikely pathogenic
(Mar 17, 2017)
criteria provided, single submitter
91.
GRCh37:
Chr9:37436681
GRCh38:
Chr9:37436684
GRHPRA297TPrimary hyperoxaluria, type IIUncertain significance
(Mar 17, 2017)
criteria provided, single submitter
92.
GRCh37:
Chr9:37429730
GRCh38:
Chr9:37429733
GRHPRQ166fsPrimary hyperoxaluria, type IILikely pathogenic
(Jan 10, 2017)
criteria provided, single submitter
93.
GRCh37:
Chr9:37436756-37436757
GRCh38:
Chr9:37436759-37436760
GRHPRM322fsPrimary hyperoxaluria, type IIUncertain significance
(Dec 15, 2016)
criteria provided, single submitter
94.
GRCh37:
Chr9:37424945-37424946
GRCh38:
Chr9:37424948-37424949
GRHPRV63fsPrimary hyperoxaluria, type IILikely pathogenic
(Jan 5, 2017)
criteria provided, single submitter
95.
GRCh37:
Chr9:37429834
GRCh38:
Chr9:37429837
GRHPRPrimary hyperoxaluria, type IILikely pathogenic
(Dec 28, 2016)
criteria provided, single submitter
96.
GRCh37:
Chr9:37426656
GRCh38:
Chr9:37426659
GRHPRPrimary hyperoxaluria, type II, not providedLikely pathogenic
(Oct 17, 2022)
criteria provided, multiple submitters, no conflicts
97.
GRCh37:
Chr9:37436747
GRCh38:
Chr9:37436750
GRHPRG319WPrimary hyperoxaluria, type II, not providedConflicting interpretations of pathogenicity
(Aug 22, 2022)
criteria provided, conflicting interpretations
98.
GRCh37:
Chr9:37424974
GRCh38:
Chr9:37424977
GRHPRPrimary hyperoxaluria, type IILikely pathogenic
(Jul 29, 2021)
criteria provided, multiple submitters, no conflicts
99.
GRCh37:
Chr9:37426584
GRCh38:
Chr9:37426587
GRHPRE113*not provided, Primary hyperoxaluria, type IIPathogenic/Likely pathogenic
(Jul 12, 2022)
criteria provided, multiple submitters, no conflicts
100.
GRCh37:
Chr9:37428511-37428512
GRCh38:
Chr9:37428514-37428515
GRHPRW145fsPrimary hyperoxaluria, type IILikely pathogenic
(Oct 10, 2016)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination